The ability to conduct weight-of-evidence assessments to inform the evaluation of potential environmental neurotoxicants is limited by lack of comparability of study methods, data analysis, and reporting. There is a need to establish consensus guidelines for conducting, analyzing, and reporting neurodevelopmental environmental epidemiologic studies, while recognizing that consistency is likewise needed for epidemiology studies examining other health outcomes. This paper proposes a set of considerations to be used by the scientific community at-large as a tool for systematically evaluating the quality of proposed and/or published studies in terms of their value for weight-of-evidence assessments. Particular emphasis is placed on evaluating factors influencing the risk of incorrect conclusions at the level of study findings. The proposed considerations are the first step in what must be a larger consensus-based process and can serve to catalyze such a discussion. Achieving consensus in these types of endeavors is difficult; however, opportunities exist for further interdisciplinary discussion, collaboration, and research that will help realize this goal. Broad acceptance and application of such an approach can facilitate the expanded use of environmental epidemiology studies of potential neurodevelopmental toxicants in the protection of public health, and specifically children's health.
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Introduction
Pediatric neurodevelopmental disorders have generated substantial attention from the scientific community, the public and media. This high visibility is due in part to an observed increased prevalence of autism spectrum disorders (Rice et al., 2010) and possibly attention deficit hyperactivity disorder (ADHD) (Pastor and Reuben, 2008) . Many chemicals are known to be human neurotoxicants, at least following acute exposure to adults (Grandjean and Landrigan, 2006) . In addition, associations between specific environmental chemicals and neuropsychiatric disorders have been reported (e.g., depression and air pollutants (Szyszkowicz et al., 2009 ); anxiety and PCB 153 (Plusquellec et al., 2010) ; ADHD and polyfluoroalkyl chemicals Neurotoxicology and Teratology 33 (2011) Contents lists available at ScienceDirect
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j o u r n a l h o m e p a g e : w w w. e l s ev i e r. c o m / l o c a t e / n e u t e ra (Hoffman et al., 2010) ; ADHD and PCBs and lead (Eubig et al., 2010) ; autism and pesticides (Roberts et al., 2007) ). In spite of the growing concerns about perturbations in neurodevelopment that may be associated with environmental exposures, few environmental chemicals are regulated on the basis of neurodevelopmental outcomes. A review of the U.S. Environmental Protection Agency (US EPA) Integrated Risk Information System (IRIS) database illustrated the limited impact of studies assessing neurodevelopmental endpoints in children have had on the characterization of hazards resulting from early life stage exposures to environmental toxicants. The IRIS database is a publicly available peer-reviewed source of toxicological information maintained by the US EPA National Center for Environmental Assessment (NCEA) for over 550 environmental chemicals (U.S. EPA, 2010a). For those chemical assessments that were issued in 1997 or later (a total of 85, listed in Table 1) , detailed hazard and dose response information is provided in a "Toxicological Review," thereby allowing an examination of the use and influence of neurobehavioral data in oral and inhalation reference value derivation. Out of the 85 assessments examined, 19 had no neurotoxicity data in either animals or humans, 24 had animal but not human neurotoxicity data, and 33 had adult human neurotoxicity data (30 of which were supported by animal data). Only 9 of the 85 IRIS toxicological databases that were examined included any information on neurotoxicity in children, and of those only 3 reported data from actual neurodevelopmental testing (the others being 2 chemicals with reports of congenital anomalies and 4 chemicals with case reports in children that suggested effects on the nervous system). The chemicals for which neurodevelopmental testing was conducted were methyl mercury, perchloroethylene, and trichloroethylene. While these data were in all cases considered qualitatively important in the weight-of-evidence evaluation of the chemical toxicity profile, methyl mercury was the only final assessment for which neurodevelopmental testing data in children were actually used as the quantitative basis for a reference value. For these particular examples, the use of the data from neurobehavioral testing in children was limited for reference value derivation by a number of considerations related to study conduct or data reporting. These included issues such as adequacy of sample size, inconsistent testing methodologies, questions about the selection or implementation of testing procedures, inadequate consideration of confounding factors, uncertainties regarding exposure characterization, reproducibility of study findings, and inconsistencies due to timing of exposure or life stage of assessment (U.S. EPA, 2010a). For two of the draft assessments (perchloroethylene and trichloroethylene) that included neurodevelopmental data in children, other toxicological outcomes were observed at lower exposure levels and thus were selected to derive reference values (U.S. EPA, 2008 EPA, , 2010b . It is important, however, to recognize the possibility that the full range of neurobehavioral outcomes at the lower end of the dose-response array may not have been fully characterized, thus limiting the weight-of-evidence evaluation of the data, and/or selection of the point of departure.
There are several factors that limit consideration of neurodevelopment in weight-of-evidence assessments. First, neurobehavioral testing in children is not mandated by any regulatory agency. Second, studies in animals may not fully capture the range of adverse outcomes in neurological development that might be observed in children. In fact, it has been noted that developmental neurotoxicity might not be evident in routine toxicology tests (Grandjean and Landrigan, 2006; Raffaele et al., 2010) . Third, use of epidemiology data in weight-of-evidence assessments has been hindered by differences in methods used in conducting neurodevelopmental epidemiologic studies as well as differences in data analysis and reporting Youngstrom et al., 2010) .
To address these and related issues, a symposium on "Advancing Neurodevelopmental Evaluation in Children: An Interdisciplinary Approach" was held on June 29, 2010 at the joint 34th annual Neurobehavioral Teratology Society, 50th annual Teratology Society, and 23rd annual Organization of Teratology Information Specialists meetings, in Louisville, KY. The objective of the symposium was to present recent multidisciplinary research centered on advancing epidemiological evaluation of children for the detection of neurobehavioral effects potentially associated with exposure to environmental chemicals and the application of these data to human health risk assessment. The symposium presentations included a critical review of commonly used neurodevelopmental tests in epidemiological studies of associations between environmental chemical exposure and adverse health effects, and tests that should be considered for future studies Kenworthy et al., 2010; Anthony et al., 2010) ; a critical review of tests used in environmental epidemiology studies of PCBs (Goodman, 2010; Goodman et al., 2010) ; discussion of a 2009 interdisciplinary Needs Assessment Workshop which resulted in innovative thinking about paths forward for neurodevelopmental function testing in environmental epidemiology ; and considerations for selection, administration, and interpretation of neurodevelopmental tests in studies of environmental chemicals. The symposium provided a forum for further discussion on advancing the science of environmental neurodevelopmental/epidemiological research.
A crucial finding of the analysis of epidemiology literature on PCBs and neurodevelopment was that our ability to conduct weight-ofevidence assessments, even with several studies, is limited when study methods, data analysis, and reporting lack comparability . Goodman et al. (2010) called for establishing consensus standards for the conduct, analysis, and reporting of neurodevelopmental environmental epidemiologic studies with the recognition that consistency is needed for epidemiology studies examining other outcomes, as well. Youngstrom et al. (2010) , in their assessment of use of neurodevelopmental function tests used in environmental epidemiology, noted that "the field of environmental epidemiology may be nearing a stage where a formal set of reporting guidelines could be developed to help the design of future studies, as has been done with clinical trials, studies of diagnostic assessment tools, and medical epidemiological studies."
We attempted to address these issues by proposing a set of considerations to be used by the scientific community at-large as a tool for systematically evaluating the quality of proposed and/or published studies in terms of their value for weight-of-evidence assessments. We specifically propose considerations and quality criteria for epidemiological research in the area of neurodevelopmental disorders and exposure to chemicals. Particular emphasis is placed on evaluating the sensitivity and specificity of the measures, as these characteristics directly affect the risk of false positive and false negative decisions at the level of the individual, thus influencing the risk of incorrect conclusions at the level of study findings.
We recognize that the considerations proposed here, which we refer to as HONEES (Harmonization of Neurodevelopmental Environmental Epidemiology Studies), are the first steps in what must be a larger consensus-based process. We hope that this serves to catalyze such a discussion. Ultimately, the end product -a clearly articulated set of standards and quality criteria -is intended to help inform the design of proposed studies and to assist funding agencies in deciding which proposals are most likely to advance the field. Perhaps most importantly, use of this type of guidance would enhance the ability of scientists to utilize results from such studies as the National Children's Study (http://www.nationalchildrensstudy.gov/Pages/default.aspx) for weight-of-evidence assessments in support of chemical regulation for developmental neurotoxicants.
Methods
The proposed considerations are modeled on the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) guidelines (von Elm et al., 2008) (http://www.strobe-statement. org/). They also incorporate elements from the STARD criteria (Standards for Reporting of Diagnostic Accuracy) for assessment studies , the Evidence Based Medicine criteria for the validity of a study of harm (Straus et al., 2005) , and prior recommendations from the fields of toxicology and psychology . These considerations were gathered, reviewed for relevance, and then collated into a more relevant set of recommendations focused on epidemiological studies related to neurodevelopment and chemical exposures.
For the purposes of reporting and evaluating studies of the neurodevelopmental effects associated with toxicant exposure, the STROBE guidelines provide an excellent starting point. STROBE includes both general recommendations and specific criteria that are relevant to longitudinal cohort studies, case control studies, and cross-sectional studies -the three major designs used to study neurodevelopmental effects of chemical exposure. For present purposes, the major contribution of the STROBE guidelines was to increase the focus on study factors that might change assessment results at the study level, such as variables that could influence the sensitivity of the assessment to exposure effects.
After comparing the tools available in the literature for evaluating epidemiological studies (STROBE), studies of diagnostic efficiency (STARD), and recent "evidence based assessment" reviews in psychology (Hunsley and Mash, 2005; 2008) , we used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) as the basis for a coding tool (Whiting et al., 2003) . The original QUADAS was derived from the 25 criteria in the STARD Guidelines for assessment studies, and the content captured the major study design and reporting elements that are common to both epidemiological (e.g., STROBE) and diagnostic (e.g., STARD) criteria, while also including a stronger emphasis on exposure and outcome assessment and discriminating accurately between groups. The QUADAS has been used in multiple reviews and meta-analyses, accumulating a substantial evidence base supporting its use (Hollingworth et al., 2006; Whiting et al., 2006) .
The QUADAS distilled the 25 recommendations from the STARD into 14 key criteria that could be coded from reports of studies in order to evaluate the quality of the study and reporting, and the potential for bias to have influenced findings. Two of these 14 criteria did not appear relevant to studies of environmental chemical exposure. One criterion (QUADAS #4) pertained to the length of time between the screening and reference standard test. The intention . Did the design avoid potential "work up" bias or differential selection of subjects for assessment between the exposed versus unexposed groups? Did the whole sample (or a random selection of the sample) receive the same assessment protocol? 9. ⁎ Did participants receive the same assessments regardless of degree of exposure to toxicant? 10. ⁎ Was the method for exposure measurement described in enough detail to permit replication or application to new cases? 11. ⁎ Is the assessment tool likely to correctly measure or classify the target construct? (adequate diagnostic sensitivity and accuracy may be particularly important for neurodevelopmental studies) 12. ⁎ Was the neurodevelopmental assessment procedure appropriate?
a. ⁎ Were methods described in sufficient detail to permit replication? b. ⁎ Was the test appropriate for the ages at which it was used? c. ⁎ Did the protocol avoid differential burden or fatigue effects across groups that might invalidate results? d. ⁎ Are there normative data for comparison, outside of the study of environmental chemicals? d Alternately, is there evidence of a dose-response gradient within the same study? e. ⁎ Was the administration valid, or were there major departures from standardization? (e.g., poor training, used outside of age norms, translated version without supporting psychometric data. Study must demonstrate evidence of good training, administration, and scoring and checks for continued administration validity across the length of the study by the review of video tapes or other similar measures) 13. ⁎ Was exposure status determined without knowledge of the results of the neurodevelopmental assessment? 14. ⁎ Were the neurodevelopmental assessment results interpreted without knowledge of the exposure status? (e.g., blinding of assessment administration and scoring staff; computerized administration) 15. ⁎ Was the contextual and supporting information used to interpret the test similar in the research protocol versus standard clinical practice? (e.g., if an assessment tool requires probing or collateral information for clinical scoring, were these additional steps also gathered as part of the research protocol?) Although internal validity of the design is paramount for drawing valid inferences from any particular study, the intent of this recommendation is to encourage reflection on whether the results generalize from the sample to the intended population. Genetic polymorphisms and diet are examples of factors that could moderate the resilience or susceptibility of different groups to the effect of toxicants.
b
If the measurement in question is truly objective, such as performed by a computer, then it will be impartial. However, this is rarely the case with neurocognitive evaluations. If the assessment involves human interaction with the subject or any degree of subjectivity in scoring, then blinding or some similar methodological safeguard would be important to protect impartiality. Either objective assessment or blinding would be sufficient. c If the design was cross-sectional, then the time period between evaluation and prior exposure should have been long enough to allow toxicant effects to manifest. Because studies of potential harm with human subjects will almost always involve quasi-experimental designs, there are well-established potential threats to validity (Campbell and Stanley, 1963) . Comparing the control group to established norms for measures can indicate whether there are secular trends influencing results, such as the Flynn Effect that has been observed with measures of cognitive ability (Flynn, 1999) . e For example, one of the most widely used behavior checklists includes several items that are supposed to be probed or queried before they are scored (Achenbach and Rescorla, 2003) , but this step is often ignored when the checklist is used in research settings, resulting in exaggerated estimates of pathology (Drotar et al., 1995) .
of Criterion #4 was to capture whether the screening and reference tests were given close enough together that the person's diagnostic status was unlikely to change in between test sessions. Treating "diagnostic change over time" as a source of bias does not appear relevant for studies of environmental chemical exposure both because the central issue is not agreement between two tests and because the diagnostic status may change over time as a result of the toxicant exposure. In fact, long-term outcomes may be a central question of interest, not a source of bias in the study design (e.g., a study may examine the relationship between a toxicant level in cord blood at birth and the children's later functioning at age 10). Thus we omitted this criterion from the revised coding tool. Similarly, a second criterion (QUADAS #7) focused on issues relevant to diagnostic screening and not to toxicant studies and was therefore omitted. The Evidence Based Medicine (EBM) guidelines for evaluating the quality of evidence for studies of harm (Straus et al., 2005) also provided a helpful set of questions and principles for evaluating studies of effects of chemical exposure. The final augmented set (Table 2 ) includes several additional criteria adapted from the EBM guidelines, as denoted in the item list. These include factors such as whether the subjects were similar in all respects except for chemical exposure, or whether the neurodevelopmental outcomes were assessed using the same methods in both the exposed and nonexposed groups (avoiding potential "work-up" bias).
Results
The product of this effort is a set of proposed considerations and recommendations (HONEES) for a process of selecting a test, evaluating its validity, and presenting findings. The main areas for evaluation of the study are Sampling and Participants, Assessment Procedures, and Interpretation and Causal Inference. In the case of the proposed considerations in Table 2 , coding would be accomplished by assigning a numerical value to a "yes" or "no" response (with the response of "unclear" leading to further evaluation of the study). The emphasis on criteria and process is consistent with the philosophy of Evidence Based Medicine and we selected the parameters in Table 2 because they have been refined over more than a decade of interdisciplinary review, they focus on evaluating and quantifying the potential risk of harm, and they include study characteristics that influence estimation of risks. New evidence continues to evolve, and existing tests will continually be revised or replaced. Thus a canonical list is ultimately a less useful product as it will be static and will grow ever more dated as the field progresses. Principles and processes, on the other hand, equip the audience to seek new data, evaluate it, and decide when to change assessment practices. The need for recommendations such as those given in Table 2 was highlighted in a review of the epidemiologic literature on PCBs and neurodevelopment .
Conclusions
The ultimate goal of conducting neurodevelopmental environmental epidemiology studies is to improve public health by providing information necessary to determine whether and how to limit exposures to specific environmental chemicals. However, even multiple, well-conducted observational studies may not provide regulatory agencies with information needed for decision-making if the methods used (including methods for measuring and expressing exposure and methods for examining associations) are not sufficiently consistent across studies. This has resulted in calls for establishing consensus standards for the conduct, analysis, and reporting of epidemiologic studies Goodman, 2010; Bellinger, 2009; Moher et al., 2010) .
The proposed considerations in Table 2 are offered as a means of catalyzing the conversation needed to build a set of consensus standards that can be used by the scientific community to encourage the type of inter-study harmonization necessary for improved weight-of-evidence assessments. These criteria can be applied prospectively, in the design of new studies, and retrospectively, in the evaluation of existing studies. Prospectively, these considerations are aspirational and offer a roadmap to research designs that will enhance the validity of findings and avoid pitfalls that pock the domain of neurocognitive assessment. Applied retrospectively to the existing literature, they offer a method for systematically evaluating studies, and possibly loosely ranking them. There is no expectation that any study would necessarily achieve all criteria, nor are the criteria all equally important, though all warrant consideration. Ultimately, for such standards to be of value, acceptance by interested parties, through round-table or consensus conferences involving key scientific and policy leaders, will be necessary. We are aware of the difficulty in achieving consensus in these types of endeavors, but opportunities exist for further interdisciplinary discussion, collaboration, and research that will help realize this goal. Broad acceptance and application of such an approach can facilitate the expanded use of environmental epidemiology studies of potential neurodevelopmental toxicants in the protection of public health, and specifically children's health.
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